CNBC April 16, 2024
Annika Kim Constantino

Key Points

– Johnson & Johnson reported first-quarter adjusted earnings that topped expectations as sales in its medical devices business surged.

– The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.

– Meanwhile, the company’s total revenue for the period came in-line with estimates.

Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical devices business surged.

Meanwhile, the company’s total revenue for the period was largely in line with estimates.

J&J’s medtech division provides devices for surgeries, orthopedics and vision. The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
New regulations to help turn tide on health care cyberattacks
Digital Health Intelligence Market Analysis: Medical Device Cyber Security
Medtronic snags FDA approval for body-sensing, closed-loop spinal cord stimulator
Oasis Or Mirage? Digital Dementia Screening In The Neurology Desert
FemTech Series: Is there a regulatory oversight in femtech?

Share This Article